BACKGROUND: Age at menarche and menstrual cycle characteristics are indicators of endocrine function and may be risk factors for diseases such as reproductive cancers. The progesterone receptor gene (PGR) has been identified as a candidate gene for age at menarche and menstrual function. METHODS: Women office workers ages 19-41 self-reported age at menarche and participated in a prospective study of menstrual function and fertility. First-morning urine was used as the DNA source. 444 women were genotyped for a functional variant in PGR, rs1042838 (Val660Leu), and 264 women were also genotyped for 29 other SNPs across the extended gene region. RESULTS: Genetic variation across PGR was associated with age at menarche using a global score statistic (p = 0.03 among non-Hispanic whites). Women carrying two copies of the Val660Leu variant experienced menarche 1 year later than women carrying one or no copies of the variant (13.6 ± 0.5 vs. 12.6 ± 0.1; p = 0.03). The Val660Leu variant was also associated with decreased odds of short menstrual cycles (17-24 days) (OR, 95% CI: 0.54 [0.36, 0.80]; p = 0.002). CONCLUSION: Genetic variation in PGR was associated with age at menarche and menstrual cycle length in this population. Further investigation of these associations in a replication dataset is warranted.
BACKGROUND: Age at menarche and menstrual cycle characteristics are indicators of endocrine function and may be risk factors for diseases such as reproductive cancers. The progesterone receptor gene (PGR) has been identified as a candidate gene for age at menarche and menstrual function. METHODS:Women office workers ages 19-41 self-reported age at menarche and participated in a prospective study of menstrual function and fertility. First-morning urine was used as the DNA source. 444 women were genotyped for a functional variant in PGR, rs1042838 (Val660Leu), and 264 women were also genotyped for 29 other SNPs across the extended gene region. RESULTS: Genetic variation across PGR was associated with age at menarche using a global score statistic (p = 0.03 among non-Hispanic whites). Women carrying two copies of the Val660Leu variant experienced menarche 1 year later than women carrying one or no copies of the variant (13.6 ± 0.5 vs. 12.6 ± 0.1; p = 0.03). The Val660Leu variant was also associated with decreased odds of short menstrual cycles (17-24 days) (OR, 95% CI: 0.54 [0.36, 0.80]; p = 0.002). CONCLUSION: Genetic variation in PGR was associated with age at menarche and menstrual cycle length in this population. Further investigation of these associations in a replication dataset is warranted.
Authors: Randi A Paynter; Danica R Skibola; Christine F Skibola; Patricia A Buffler; Joseph L Wiemels; Martyn T Smith Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-12 Impact factor: 4.254
Authors: Karen A Pooley; Catherine S Healey; Paula L Smith; Paul D P Pharoah; Deborah Thompson; Louise Tee; Judith West; Clare Jordan; Douglas F Easton; Bruce A J Ponder; Alison M Dunning Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-04 Impact factor: 4.254
Authors: Daniela B Leite; Michele G Junqueira; Cristina V de Carvalho; Ana M Massad-Costa; Wagner J Gonçalves; Sergio M Nicolau; Luiz A F Lopes; Edmundo C Baracat; Ismael D C G da Silva Journal: Steroids Date: 2008-02-23 Impact factor: 2.668
Authors: Nike M M L Stikkelbroeck; C G J Sweep; Didi D M Braat; Ad R M M Hermus; Barto J Otten Journal: Fertil Steril Date: 2003-10 Impact factor: 7.329
Authors: Sharon E Johnatty; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; John L Hopper; David L Duffy; Georgia Chenevix-Trench Journal: Breast Cancer Res Treat Date: 2007-06-26 Impact factor: 4.872
Authors: C L Pearce; A H Wu; S A Gayther; A E Bale; P A Beck; J Beesley; S Chanock; D W Cramer; R DiCioccio; R Edwards; Z S Fredericksen; M Garcia-Closas; E L Goode; A C Green; L C Hartmann; E Hogdall; S K Kjaer; J Lissowska; V McGuire; F Modugno; K Moysich; R B Ness; S J Ramus; H A Risch; T A Sellers; H Song; D O Stram; K L Terry; P M Webb; D C Whiteman; A S Whittemore; W Zheng; P D P Pharoah; G Chenevix-Trench; M C Pike; J Schildkraut; A Berchuck Journal: Br J Cancer Date: 2008-01-22 Impact factor: 7.640
Authors: Irene M Shui; Lorelei A Mucci; Peter Kraft; Rulla M Tamimi; Sara Lindstrom; Kathryn L Penney; Katharina Nimptsch; Bruce W Hollis; Natalie Dupre; Elizabeth A Platz; Meir J Stampfer; Edward Giovannucci Journal: J Natl Cancer Inst Date: 2012-04-12 Impact factor: 13.506